| 发明名称 |
TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES WITH EPRATUZUMAB |
| 摘要 |
<p>The invention relates to the treatment of autoimmune or inflammatory disorders with antibodies to CD22. In particular, the invention relates to the treatment of autoimmune or inflammatory disorders with epratuzumab with a new dosing regimen. More particularly, the invention relates to the treatment of SLE.</p> |
| 申请公布号 |
IN2196DEN2012(A) |
申请公布日期 |
2015.08.21 |
| 申请号 |
IN2012DE02196 |
申请日期 |
2012.03.13 |
| 申请人 |
UCB PHARMA, S.A. |
发明人 |
NOVOTNEY-BARRY, ANNA-MARIE;HULHOVEN, REGINALD;PARKER, GERALD, L.;HOSKIN, VIOLET, A. |
| 分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
